Axonis Therapeutics Funding: $157M Raised, Series A (2024)
Axonis Therapeutics is a Biotech company based in Boston. It has raised $157M in total funding. Latest round: Series A.
Axonis Therapeutics funding overview
Axonis Therapeutics is a Biotech company based in Boston. Axonis Therapeutics has raised $157M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2024. The round record for Axonis Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Cormorant Asset Management, venBio Partners, Sofinnova Investments, MRL Ventures Fund, Perceptive Advisors, Solasta Ventures and 7 others. 13 distinct backers are named across the disclosed rounds.
Frequently asked about Axonis Therapeutics funding
How much has Axonis Therapeutics raised?
Axonis Therapeutics has raised $157M in total disclosed funding across the rounds on record.
Who has invested in Axonis Therapeutics?
Cormorant Asset Management, venBio Partners, Sofinnova Investments, MRL Ventures Fund, Perceptive Advisors, Solasta Ventures are named among the investors backing Axonis Therapeutics.
What was the latest Axonis Therapeutics funding round?
The most recent disclosed round is a Series A, announced in October 2024.
Where is Axonis Therapeutics based?
Axonis Therapeutics is based in Boston.
What sector does Axonis Therapeutics operate in?
Axonis Therapeutics is tracked under Biotech from Boston, with $157M in disclosed funding.
When did Axonis Therapeutics last raise?
The last disclosed Axonis Therapeutics round closed in October 2024 at Series A.
We update the Axonis Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Boston and their backers are listed below.
